Boothbay Fund Management’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.52M Buy
238,749
+203,908
+585% +$6.42M 0.1% 204
2025
Q4
$1.03M Buy
34,841
+4,705
+16% +$131K 0.02% 787
2025
Q3
$761K Buy
30,136
+6,050
+25% +$147K 0.01% 952
2025
Q2
$578K Sell
24,086
-9,675
-29% -$224K 0.01% 863
2025
Q1
$773K Sell
33,761
-7,525
-18% -$182K 0.02% 714
2024
Q4
$1.05M Sell
41,286
-47,150
-53% -$1.19M 0.03% 623
2024
Q3
$2.2M Buy
88,436
+40,598
+85% +$1.2M 0.05% 489
2024
Q2
$1.42M Buy
47,838
+10,463
+28% +$290K 0.03% 610
2024
Q1
$1.13M Buy
37,375
+20,620
+123% +$572K 0.02% 721
2023
Q4
$479K Buy
+16,755
New +$492K 0.01% 1000

Other funds holding RTO

Boothbay Fund Management's RTO Position: Q1 2026 in Review

Boothbay Fund Management increased its Rentokil (RTO) stake by 585% in Q1 2026, buying an estimated $6.42M and bringing the position to 238,749 shares worth $7.52M. The position accounts for 0.1% of the portfolio, ranked #204.

Boothbay Fund Management first reported a position in RTO in Q4 2023 and has held it in 10 quarters since. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Boothbay Fund Management held 238,749 shares of Rentokil worth $7.52M as of Q1 2026.
  • Boothbay Fund Management bought 203,908 Rentokil shares in Q1 2026, an estimated $6.42M.
  • Rentokil made up 0.1% of Boothbay Fund Management's portfolio in Q1 2026, its #204 holding.
  • Boothbay Fund Management first reported a position in Rentokil in Q4 2023 and has held it in 10 quarters since.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.